Published in Hepatitis Weekly, June 29th, 1998
"This two-year safety review reveals few unexpected hepatitis A virus (HAV) vaccine-associated serious events, despite the use of at least six million vaccine doses in the United States, and it reaffirms the safety of the newly licensed HAV vaccines in the general population," Manette T. Niu and colleagues from the U.S. Food and Drug Administration's Vaccine Adverse Event Reporting System (VAERS) wrote ("Two-Year Review of Hepatitis A Vaccine Safety: Data from VAERS," Clinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.